These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15734875)

  • 1. Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density.
    Gregorevic P; Ryall JG; Plant DR; Sillence MN; Lynch GS
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H344-9. PubMed ID: 15734875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.
    Ryall JG; Plant DR; Gregorevic P; Sillence MN; Lynch GS
    J Physiol; 2004 Feb; 555(Pt 1):175-88. PubMed ID: 14617677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats.
    Osadchii O; Norton G; Deftereos D; Muller D; Woodiwiss A
    Eur J Pharmacol; 2006 Dec; 553(1-3):246-53. PubMed ID: 17056037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury.
    Beitzel F; Gregorevic P; Ryall JG; Plant DR; Sillence MN; Lynch GS
    J Appl Physiol (1985); 2004 Apr; 96(4):1385-92. PubMed ID: 14607853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of responsiveness to adrenoceptor agonists and calcium of non-infarcted hypertrophied muscles from rats with chronic myocardial infarction.
    Itaya T; Hashimoto H; Uematsu T; Nakashima M
    Br J Pharmacol; 1990 Mar; 99(3):572-6. PubMed ID: 1970501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
    Ryall JG; Sillence MN; Lynch GS
    Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle.
    Schertzer JD; Plant DR; Ryall JG; Beitzel F; Stupka N; Lynch GS
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E526-33. PubMed ID: 15479951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice.
    Faulx MD; Ernsberger P; Vatner D; Hoffman RD; Lewis W; Strachan R; Hoit BD
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H30-6. PubMed ID: 15749746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished responsiveness to cardiac beta 1-adrenoceptor agonists in rats with chronic heart failure following myocardial infarction.
    Sanbe A; Takeo S
    Biol Pharm Bull; 1995 Oct; 18(10):1362-6. PubMed ID: 8593437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
    Sanbe A; Takeo S
    Circulation; 1995 Nov; 92(9):2666-75. PubMed ID: 7586371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.
    Ryall JG; Gregorevic P; Plant DR; Sillence MN; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2002 Dec; 283(6):R1386-94. PubMed ID: 12388476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity constants and beta-adrenoceptor reserves for isoprenaline on cardiac tissue from normotensive and hypertensive rats.
    Doggrell SA; Petcu EB; Barnett CW
    J Pharm Pharmacol; 1998 Feb; 50(2):215-23. PubMed ID: 9530991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct actions of intermittent and sustained β-adrenoceptor stimulation on cardiac remodeling.
    Ma X; Song Y; Chen C; Fu Y; Shen Q; Li Z; Zhang Y
    Sci China Life Sci; 2011 Jun; 54(6):493-501. PubMed ID: 21706409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-andrenoceptors in the hearts of diabetic-hypertensive rats: radioligand binding and functional experiments.
    Beenen OH; Batink HD; Pfaffendorf M; van Zwieten PA
    Blood Press; 1997 Jan; 6(1):44-51. PubMed ID: 9116926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of aging on electrical, mechanical, and coronary modification induced by ouabain and epinine in isolated rat heart.
    Abete P; Caccese P; Landino P; Cioppa A; Abate R; Ciaburri F; Ferrara P; De Caprio L; Ferrara N; Rengo F
    Cardiovasc Res; 1994 Mar; 28(3):358-64. PubMed ID: 8174156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic beta2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity.
    Ryall JG; Schertzer JD; Murphy KT; Allen AM; Lynch GS
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2587-95. PubMed ID: 18408128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats.
    Godlewski G; Schlicker E; Baranowska U; Malinowska B
    Shock; 2006 Nov; 26(5):510-5. PubMed ID: 17047523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat.
    Wang X; Ren B; Liu S; Sentex E; Tappia PS; Dhalla NS
    J Appl Physiol (1985); 2003 Feb; 94(2):752-63. PubMed ID: 12531914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic response of the rat heart during development and regression of triiodothyronine-induced hypertrophy.
    Lortet S; Zimmer HG; Rossi A
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):707-12. PubMed ID: 2481184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.